BGAI
IONS icon

Bruce G. Allen Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Bruce G. Allen Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82K Hold
23
– – ﹤0.01% 706
2026
Q1 		$1.73K Hold
23
– – ﹤0.01% 714
2025
Q4 		$1.82K Hold
23
– – ﹤0.01% 712
2025
Q3 		$1.5K Hold
23
– – ﹤0.01% 752
2025
Q2 		$909 Buy
23
+10
+77% +$327 ﹤0.01% 843
2025
Q1 		$392 Buy
+13
New +$426 ﹤0.01% 984

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bruce G. Allen Investments's IONS Position: Q2 2026 in Review

Bruce G. Allen Investments held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 23 shares worth $1.82K. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Bruce G. Allen Investments first reported a position in IONS in Q1 2025 and has held it in 6 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Bruce G. Allen Investments held 23 shares of Ionis Pharmaceuticals worth $1.82K as of Q2 2026.
  • Bruce G. Allen Investments left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #706 holding.
  • Bruce G. Allen Investments first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.